NCT06709690 A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
| NCT ID | NCT06709690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ruijin Hospital |
| Condition | Paediatric Patients |
| Study Type | OBSERVATIONAL |
| Enrollment | 35 participants |
| Start Date | 2024-10-25 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 35 participants in total. It began in 2024-10-25 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the feasibility of deep learning-assisted rapid silent PET/MR in pediatric applications.
Eligibility Criteria
Inclusion Criteria: 1. Children who have clinical symptoms and are suspected of having malignant tumors after being evaluated by clinical pediatricians and require 18F-FDG PET/MR examination to further clarify their conditions. 2. Signed and dated informed consent form 3. Commit to complying with the research procedures and cooperate in the implementation of the entire research process. 4. No gender restriction, aged between 0 and 18 years old. Exclusion Criteria: 1. Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc. 2. Patients with severe claustrophobia，epileptic seizures, respiratory distress who cannot lie down, and patients with mental anomalies who are unable to cooperate. 3. Patients with metal implants such as pacemakers, artificial metal heart valves, and neurostimulators in their bodies. 4. Non-compliant person.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06709690 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Paediatric Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06709690 currently recruiting?
Yes, NCT06709690 is actively recruiting participants. Contact the research team at jiajiahu@shsmu.edu.cn for enrollment information.
Where is the NCT06709690 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06709690 clinical trial?
NCT06709690 is sponsored by Ruijin Hospital. The trial plans to enroll 35 participants.